Skip to content
Try Mental Wellness – Lifestyle
Author:
Arvinas Inc.
Arvinas to Present Phase 1 Data for ARV-102, a PROTAC LRRK2 Degrader, in Oral Session at the 2026 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders
March 11, 2026
←
Previous Page
1
2